Slower progression of amyotrophic lateral sclerosis with external application of a Chinese herbal plaster–The randomized, placebo-controlled triple-blinded ALS-CHEPLA trial

Slower progression of amyotrophic lateral sclerosis with external application of a Chinese herbal plaster–The randomized, placebo-controlled triple-blinded ALS-CHEPLA trial

BackgroundAmyotrophic lateral sclerosis (ALS) is a chronic neurodegenerative disease characterized by gradually increasing damage to the upper and lower motor neurons. However, definitive and efficacious treatment for ALS is not available, and oral intake in ALS patients with bulbar involvement is c...

Full description

Bibliographic Details
Main Authors: Sven Schröder, Mingzhe Wang, Dandan Sima, Joana Schröder, Xuying Zhu, Xuanlu Zheng, Lin Liu, Tingying Li, Qiudong Wang, Thomas Friedemann, Te Liu, Weidong Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Neurology
Subjects:
sporadic amyotrophic lateral sclerosis
RTC
placebo control
herbal plaster
Traditional Chinese Medicine
dysphagia
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.990802/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.990802/full

Similar Items